IMA vs V · rev $9.2M vs P/E 33, rev $40.00B
ImageneBio, Inc. (IMA) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
IMA currently screens at market cap $64.7M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the IMA and V stock pages for the full models.
Not investment advice.